Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro
April 03, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has...
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
April 01, 2024 07:00 ET
|
Venus Concept Inc.
TORONTO, April 01, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
March 25, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO) announced today that it received a decision from the Nasdaq Hearings Panel (the...
Venus Concept Launches “NEXThetics” Program
March 12, 2024 16:05 ET
|
Venus Concept Inc.
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the launch of “NEXThetics”,...
Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
February 27, 2024 16:05 ET
|
Venus Concept Inc.
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has closed its...
Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
February 23, 2024 08:00 ET
|
Venus Concept Inc.
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered...
Venus Concept Announces CE Mark for Venus Versa Pro in Europe
February 22, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received...
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
February 20, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and...
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
February 06, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will...
Venus Concept Inc. Announces Review of Strategic Alternatives
January 24, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that its Board of...